Suraksha Diagnostic IPO sees weak response, with 37% subscription; analysts advise avoiding due to high valuation and limited market presence.
Positive Breakout: These 13 stocks cross above their 200 DMAs
In the Nifty500 pack, 13 stocks’ closing prices crossed above their 200 DMA (Daily Moving Averages) on March 5, 2026, according to stockedge.com’s technical scan